Brief: Femasys Begins Fembloc Pivotal Trial Enrollment At UC Davis Medical Center
26/01/2024 13:09
Jan 26 (Reuters) - Femasys Inc FEMY.O :
* FEMASYS INC. BEGINS FEMBLOC PIVOTAL TRIAL ENROLLMENT AT UC
DAVIS
MEDICAL CENTER, A HUB FOR INNOVATION AND GROUNDBREAKING RESEARCH
IN HEALTH CARE FOR WOMEN
Source text for Eikon: ID:nGNX9H5VTz
Further company coverage: FEMY.O
((Reuters.Briefs@thomsonreuters.com;))